Biomaterial: Dental Implants and Biomaterials

Publication date: January 2011

Keywords : Dental bone graft, biomaterials, dental biomaterial, dental bone graft substitute, Biomaterial

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Industry expert's new report, “” provides key data, information and analysis on the global dental implants and biomaterials industry . The report provides industry landscape, competitive landscape and industry trends data on the dental implants and biomaterials industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape and technology offerings.

Scope of the Research

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key sectors covered include titanium dental implants, zirconium dental implants, dental bone grafts, dental bone graft substitutes, and tissue regenerative materials.
- Annualized industry revenues data from 2002 to 2009, projection forward for 7 years to 2016. Firms shares data for 2009.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within dental implants and biomaterials industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include Nobel Biocare Holding AG, Straumann Holding AG, BIOMET 3i, Inc., DENTSPLY International Inc., Zimmer Holdings, Inc. and Geistlich Pharma AG.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the dental implants and biomaterials industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the dental implants and biomaterials industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the global dental implants and biomaterials industry and the factors shaping it.

Global Biomaterial Industry

1 Table of Contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 8

II Introduction 9
II. 1 GlobalData Report Guidance 9

III Dental Implants and Biomaterials 10
III. 1 Overview 10
4 World Dental Implants and Biomaterials: March ket Characterization 12
IV. 1 Dental Implants and Biomaterials March ket, Global, Sales (USD Million), Historical data, 2002–2009 12
IV. 2 Dental Implants and Biomaterials March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 14
IV. 3 Dental Implants and Biomaterials, March ket Trends 15
IV. 3.1 Total Time Period for the Implantation Procedure to be Performed is December reasing with Improvements in Technology 15
IV. 3.2 Nanotechnology in Implant Design Aids in Enhancing the Implant Surface 15
IV. 3.3 Increasing Digitization of the March ket Improves the Patient Comfort and Provides Better Solutions 16
IV. 3.4 Emergence of Alternative Treatment Therapies Could Restrict the March ket Growth 16
IV. 4 World Dental Implants and Biomaterials, March ket Dynamics 17
IV. 4.1 Dental Implants and Biomaterials, March ket Drivers 17
IV. 4.2 Dental Implants and Biomaterials, March ket Restraints 24
5 World Dental Implants and Biomaterials March ket: Segment Analysis 27
V. 1 Dental Implants 27
V. 1.1 Titanium Dental Implants March ket, Global, Sales ($bn), Historical data, 2002–2009 28
V. 1.2 Titanium Dental Implants March ket, Global, Sales ($bn), Forecasted data, 2009–2016 29
V. 1.3 Titanium Dental Implants, March ket Drivers 30
V. 1.4 Titanium Dental Implants, March ket Restraint: Health Concerns Following the Insertion of Titanium Implants Could Potentially Restrict the March ket Growth 30
V. 1.5 Zirconium Dental Implants March ket, Global, Sales (USD Million), Historical data, 2002–2009 31
V. 1.6 Zirconium Dental Implants March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 32
V. 1.7 Zirconium Dental Implants, March ket Drivers 33
V. 1.8 Zirconium Dental Implants, March ket Restraints 33
V. 2 Dental Biomaterials 34
V. 2.1 Dental Bone Grafts March ket, Global, Sales (USD Million), Historical data, 2002–2009 35
V. 2.2 Dental Bone Grafts March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 36
V. 2.3 Dental Bone Grafts, March ket Driver: Positive Outcomes of Allograft and Xenograft Materials Would Drive the Use of Bone Grafts 36
V. 2.4 Dental Bone Grafts, March ket Restraints 36
V. 2.5 Tissue Regenerative Materials March ket, Global, Sales (USD Million), Historical data, 2002–2009 37
V. 2.6 Tissue Regenerative Materials March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 38
V. 2.7 Tissue Regenerative Materials, March ket Driver: Tissue Regenerative Materials March ket is Expected to Grow with Increasing Popularity of Oral Surgical Procedures 38
V. 2.8 Tissue Regenerative Materials, March ket Restraint: Ease of Manufacturing Would Lead to Crowding of the March ket by Small Local Players, Effectively Restricting March ket Sales s by Offering Low Cost Solutions. 39
V. 2.9 Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), Historical data, 2002–2009 39
V. 2.10 Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), Forecasted data, 2009–2016 40
V. 2.11 Dental Bone Graft Substitutes, March ket Drivers 41
V. 2.12 Dental Bone Graft Substitutes, March ket Restraint: Risk of Graft Rejection in Some Patients Could Potentially Defame the Use of Bone Graft Substitutes, Negatively Affecting the March ket 41
V. 3 March ket Opportunities and Risk Evaluation 42

VI Dental Implants and Biomaterials March ket, by Country, 2002–2016 44
VI. 1 Dental Implants and Biomaterials March ket, US, Sales (USD Million), Historical data, 2002–2009 44
VI. 2 Dental Implants and Biomaterials March ket, US, Sales (USD Million), Forecasted data, 2009–2016 45
VI. 3 Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), Historical data, 2002–2009 47
VI. 4 Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), Forecasted data, 2009–2016 48
VI. 5 Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), Historical data, 2002–2009 49
VI. 6 Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), Forecasted data, 2009–2016 50
VI. 7 Dental Implants and Biomaterials March ket, UK, Sales (USD Million), Historical data, 2002–2009 51
VI. 8 Dental Implants and Biomaterials March ket, UK, Sales (USD Million), Forecasted data, 2009–2016 53
VI. 9 Dental Implants and Biomaterials March ket, France, Sales (USD Million), Historical data, 2002–2009 54
VI. 10 Dental Implants and Biomaterials March ket, France, Sales (USD Million), Forecasted data, 2009–2016 55
VI. 11 Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), Historical data, 2002–2009 56
VI. 12 Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), Forecasted data, 2009–2016 58
VI. 13 Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), Historical data, 2002–2009 59
VI. 14 Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), Forecasted data, 2009–2016 60
VI. 15 Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), Historical data, 2002–2009 61
VI. 16 Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), Forecasted data, 2009–2016 62
VI. 17 Dental Implants and Biomaterials March ket, China, Sales (USD Million), Historical data, 2002–2009 63
VI. 18 Dental Implants and Biomaterials March ket, China, Sales (USD Million), Forecasted data, 2009–2016 64
VI. 19 Dental Implants and Biomaterials March ket, India, Sales (USD Million), Historical data, 2002–2009 65
VI. 20 Dental Implants and Biomaterials March ket, India, Sales (USD Million), Forecasted data, 2009–2016 66
VI. 21 Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), Historical data, 2002–2009 67
VI. 22 Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), Forecasted data, 2009–2016 68
VI. 23 Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), Historical data, 2002–2009 69
VI. 24 Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), Forecasted data, from 2009 to 2016 70
7 World Dental Implants and Biomaterials March ket: Strategic Competitive Assesment 71
VII. 1 Strategic Competitive Assessment Matrix 73
VII. 2 Nobel Biocare Holding AG 73
VII. 2.1 Overview 73
VII. 2.2 Key March keted Products 73
VII. 3 Geistlich Pharma AG 76
VII. 3.1 Overview 76
VII. 3.2 March keted Products 76
VII. 4 Straumann Holding AG 77
VII. 4.1 Overview 77
VII. 4.2 March keted Products 77
VII. 5 BIOMET 3i, Inc. 79
VII. 5.1 Overview 79
VII. 5.2 March keted Products 79
VII. 6 DENTSPLY International Inc. 81
VII. 6.1 Overview 81
VII. 6.2 March keted Products 81
8 World Dental Implants and Biomaterials March ket, Strategic Pipeline Assessment 82
VIII. 1 Dental Implants and Biomaterials March ket, Pipeline Products Summary 82
VIII. 2 Profiles of Promising Products Under Clinical Development: 83
VIII. 2.1 MD06 Activated Implant 83
VIII. 2.2 New Extra Short Implant 83
VIII. 2.3 Next Generation NobelReplace 83
VIII. 2.4 NobelActive-3mm 83
VIII. 2.5 OSSEOTITE II 84
VIII. 2.6 Dental Implants Overdenture Implant 84
VIII. 2.7 RODO Device 84

IX Dental Implants and Biomaterials March ket, Strategic Deals Analysis 85
IX. 1 Deals Analysis 85
IX. 2 Key Deals 87
IX. 2.1 RTI Biologics Enters into Worldwide Distribution Agreement with Zimmer Dental 87
IX. 2.2 Astra Tech Signs an Agreement with University of Zurich 88
IX. 2.3 BioHorizons Implant Systems Takes Over Implant Logic Systems 88
IX. 2.4 Nobel Biocare Takes Over AlphaBioTec 89
IX. 2.5 Astra Tech Takes Over Atlantis Components 89

X Appendix 90
X. 1 Definitions 90
X. 1.1 Dental Implants 90
X. 1.2 Dental Biomaterials 91
X. 2 Acronyms 91
X. 3 Sources 92
X. 3.1 Associations, Government Organizations: 92
X. 3.2 Journals / Scholarly Article Sources: 92
X. 3.3 Annual Reports, Press Release, Firms Websites 92
X. 3.4 Various News articles 92
X. 4 Research Methodology 92
X. 5 Secondary Research 93
X. 6 Primary Research 93
X. 7 Models 93
X. 8 Forecasted data s 94
X. 9 Expert Panels 94
X. 10 GlobalData Consulting 94
X. 11 Contact Us 94
X. 12 Disclaimer 94

1.1 List of Data tables

Data table 1: Dental Implants and Biomaterials March ket, Global, Sales (USD Million), 2002–2009 12
Data table 2: Dental Implants and Biomaterials March ket, Global, Sales (USD Million), 2009–2016 14
Data table 3: Dental Implants and Biomaterials March ket, Global, Increase in Elderly Population, 2010 18
Data table 4: Dental Implants and Biomaterials March ket, Global, Prevalence of Edentulousness, 2010 18
Data table 5: Dental Implants and Biomaterials March ket, Global, Indicative Procedure Volumes, Implant Surgery, 2006–2012 24
Data table 6: Titanium Dental Implants March ket, Global, Sales ($ bn), 2002–2009 28
Data table 7: Titanium Dental Implants March ket, Global, Sales ($bn), 2009–2016 29
Data table 8: Zirconium Dental Implants March ket, Global, Sales (USD Million), 2002–2009 31
Data table 9: Zirconium Dental Implants March ket, Global, Sales (USD Million), 2009–2016 32
Data table 10: Dental Bone Grafts March ket, Global, Sales (USD Million), 2002–2009 35
Data table 11: Dental Bone Grafts March ket, Global, Sales (USD Million), 2009–2016 36
Data table 12: Tissue Regenerative Materials March ket, Global, Sales (USD Million), 2002–2009 37
Data table 13: Tissue Regenerative Materials March ket, Global, Sales (USD Million), 2009–2016 38
Data table 14: Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), 2002–2009 39
Data table 15: Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), 2009–2016 40
Data table 16: Dental Implants and Biomaterials March ket, US, Sales (USD Million), from 2002 to 2009 44
Data table 17: Dental Implants and Biomaterials March ket, US, Sales (USD Million), from 2009 to 2016 46
Data table 18: Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), from 2002 to 2009 47
Data table 19: Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), 2009–2016 48
Data table 20: Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), 2002–2009 49
Data table 21: Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), 2009–2016 50
Data table 22: Dental Implants and Biomaterials March ket, UK, Sales (USD Million), 2002–2009 52
Data table 23: Dental Implants and Biomaterials March ket, UK, Sales (USD Million), 2009–2016 53
Data table 24: Dental Implants and Biomaterials March ket, France, Sales (USD Million), 2002–2009 54
Data table 25: Dental Implants and Biomaterials March ket, France, Sales (USD Million), 2009–2016 55
Data table 26: Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), 2002–2009 57
Data table 27: Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), 2009–2016 58
Data table 28: Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), from 2002 to 2009 59
Data table 29: Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), 2009–2016 60
Data table 30: Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), from 2002 to 2009 61
Data table 31: Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), 2009–2016 62
Data table 32: Dental Implants and Biomaterials March ket, China, Sales (USD Million), 2002–2009 63
Data table 33: Dental Implants and Biomaterials March ket, China, Sales (USD Million), 2009–2016 64
Data table 34: Dental Implants and Biomaterials March ket, India, Sales (USD Million), 2002–2009 65
Data table 35: Dental Implants and Biomaterials March ket, India, Sales (USD Million), 2009–2016 66
Data table 36: Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), 2002–2009 67
Data table 37: Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), 2009–2016 68
Data table 38: Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), 2002–2009 69
Data table 39: Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), 2009–2016 70
Data table 40: Dental Implants March ket, Global, Firms Sales (USD Million), 2009 71
Data table 41: Dental Biomaterials March ket, Global, Firms Sales (USD Million), 2009 72
Data table 42: Features and Benefits, Nobel Biocare, Key March keted Product – NobelActive 74
Data table 43: Features and Benefits, Nobel Biocare, Key March keted Product - NobelReplace 74
Data table 44: Features and Benefits, Nobel Biocare, Key March keted Product – NobelSpeedy 74
Data table 45: Features and Benefits, Nobel Biocare, Key March keted Product – Brånemark System 75
Data table 46: Features and Benefits, Nobel Biocare, Key March keted Product – Abutments 75
Data table 47: Features and Benefits, Geistlich Pharma, Key March keted Product – Geistlich Bio-Oss 76
Data table 48: Features and Benefits, Geistlich Pharma, Key March keted Product – Geistlich Bio-Gide 76
Data table 49: Features and Benefits, Straumann Holding, Key March keted Product – Standard Implant 77
Data table 50: Features and Benefits, Straumann Holding, Key March keted Product – Standard Plus Implant 77
Data table 51: Features and Benefits, Straumann Holding, Key March keted Product – Standard Plus Implant 78
Data table 52: Features and Benefits, Straumann Holding, Key March keted Product – Bone Level Implant 78
Data table 53: Features and Benefits, Straumann Holding, Key March keted Product – BoneCeramic 78
Data table 54: Features and Benefits, Biomet 3i, Key March keted Product – NanoTite Surface Technology Based Products 79
Data table 55: Features and Benefits, Biomet 3i, Key March keted Product – OSSEOTITE Surface Technology Based Products 79
Data table 56: Features and Benefits, Biomet 3i, Key March keted Product – RegenerOss System 80
Data table 57: Features and Benefits, Biomet 3i, Key March keted Product – Biogran 80
Data table 58: Features and Benefits, Biomet 3i, Key March keted Product – OsseoGuard 80
Data table 59: Features and Benefits, Dentsply, Key March keted Product – Ankylos 81
Data table 60: Dental Implants and Biomaterials March ket, Global, Pipeline Products Summary, 2010 82
Data table 61: Dental Implants and Biomaterials March ket, Global, Number of Deals, 2005–2010 (until Q3) 85
Data table 62: Dental Implants and Biomaterials March ket, Global, Type of Deals, Number of Deals, 2007–September tember 2010 86

1.2 List of Charts

Chart 1: The Process of Dental Implantation 10
Chart 2: Dental Implants and Biomaterials March ket, Global, Sales (USD Million), 2002–2009 12
Chart 3: Dental Implants and Biomaterials March ket, Global, Sales (USD Million), 2009–2016 14
Chart 4: Dental Implants and Biomaterials, March ket Dynamics 17
Chart 5: Rising Disposable Income, Selected Countries, 2002–2008 19
Chart 6: Dental Implants and Biomaterials March ket, March keting Approach Adopted by Firms, 2010 20
Chart 7: Dental Implants and Biomaterials, Value Chain Integration Initiatives by Firms, 2010 21
Chart 8: Titanium Dental Implants March ket, Global, Sales ($bn), 2002–2009 28
Chart 9: Titanium Dental Implants March ket, Global, Sales ($bn), 2009–2016 29
Chart 10: Zirconium Dental Implants March ket, Global, Sales (USD Million), 2002–2009 31
Chart 11: Zirconium Dental Implants March ket, Global, Sales (USD Million), 2009–2016 32
Chart 12: Dental Bone Grafts March ket, Global, Sales (USD Million), 2002–2009 35
Chart 13: Dental Bone Grafts March ket, Global, Sales (USD Million), 2009–2016 36
Chart 14: Tissue Regenerative Materials March ket, Global, Sales (USD Million), 2002–2009 37
Chart 15: Tissue Regenerative Materials March ket, Global, Sales (USD Million), 2009–2016 38
Chart 16: Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), 2002–2009 39
Chart 17: Dental Bone Graft Substitutes March ket, Global, Sales (USD Million), 2009–2016 40
Chart 18: Dental Implants and Biomaterials March ket, Global, March ket Opportunities and Risk Evaluation, 2010 42
Chart 19: Dental Implants and Biomaterials March ket, US, Sales (USD Million), 2002–2009 44
Chart 20: Dental Implants and Biomaterials March ket, US, Sales (USD Million), 2009–2016 45
Chart 21: Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), 2002–2009 47
Chart 22: Dental Implants and Biomaterials March ket, Canada, Sales (USD Million), 2009–2016 48
Chart 23: Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), 2002–2009 49
Chart 24: Dental Implants and Biomaterials March ket, Germany, Sales (USD Million), 2009–2016 50
Chart 25: Dental Implants and Biomaterials March ket, UK, Sales (USD Million), 2002–2009 51
Chart 26: Dental Implants and Biomaterials March ket, UK, Sales (USD Million), 2009–2016 53
Chart 27: Dental Implants and Biomaterials March ket, France, Sales (USD Million), 2002–2009 54
Chart 28: Dental Implants and Biomaterials March ket, France, Sales (USD Million), 2009–2016 55
Chart 29: Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), 2002–2009 56
Chart 30: Dental Implants and Biomaterials March ket, Spain, Sales (USD Million), 2009–2016 58
Chart 31: Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), 2002–2009 59
Chart 32: Dental Implants and Biomaterials March ket, Italy, Sales (USD Million), 2009–2016 60
Chart 33: Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), 2002–2009 61
Chart 34: Dental Implants and Biomaterials March ket, Japan, Sales (USD Million), 2009–2016 62
Chart 35: Dental Implants and Biomaterials March ket, China, Sales (USD Million), 2002–2009 63
Chart 36: Dental Implants and Biomaterials March ket, China, Sales (USD Million), 2009–2016 64
Chart 37: Dental Implants and Biomaterials March ket, India, Sales (USD Million), 2002–2009 65
Chart 38: Dental Implants and Biomaterials March ket, India, Sales (USD Million), 2009–2016 66
Chart 39: Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), 2002–2009 67
Chart 40: Dental Implants and Biomaterials March ket, Australia, Sales (USD Million), 2009–2016 68
Chart 41: Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), 2002–2009 69
Chart 42: Dental Implants and Biomaterials March ket, Brazil, Sales (USD Million), 2009–2016 70
Chart 43: Dental Implants March ket, Global, Market Shares s (%), 2009 71
Chart 44: Dental Biomaterials March ket, Global, Market Shares s (%), 2009 72
Chart 45: Dental Implants and Biomaterials March ket, Global, Strategic Competitive Assessment Matrix, 2010 73
Chart 46: Dental Implants and Biomaterials March ket, Global, Pipeline Products by Development Stage, 2010 82
Chart 47: Dental Implants and Biomaterials March ket, Global, Number of Deals, 2005–2010 (until Q3) 85
Chart 48: Dental Implants and Biomaterials March ket, Global, Type of Deals, Number of Deals, 2007–September tember 2010 86

Companies mentioned
Nobel Biocare Holding AG
Geistlich Pharma AG
Straumann Holding AG
BIOMET 3i, Inc.
DENTSPLY International Inc.

Talk to Alison

00 1 718 618 48 97

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Global Biomaterial Industry : Latest Reports

PolyNovo Biomaterials Pty Ltd - Medical Equipment - Deals and Alliances Profile, Global Data

$ 250
Company report
January 2013
by Global Data

Summary PolyNovo Biomaterials Pty Ltd (PolyNovo) is a medical device company, based in Australia. It manufactures, develops and markets biodegradable polymers technology. The company's product NovoSo ...

PolyNovo Biomaterials Pty Ltd - Medical Equipment - Deals and Alliances Profile, Global Data

$ 250
Company report
April 2013
by Global Data

Summary PolyNovo Biomaterials Pty Ltd (PolyNovo) is a medical technology company. The company develops and markets biodegradable polymers. Its technology, Novosorb is a biodegradable medical polymers, ...

Geistlich Pharma AG Market Share Analysis

$ 1 000
Company report
December 2012
by Global Data

Geistlich Pharma AG Market Share Analysis Summary GlobalData's new report, ?Geistlich Pharma AG Market Share Analysis? provides in-depth information on Geistlich Pharma AG's market position in the dental ...

More Reports:

Biomaterial in China (16)

Biomaterial in the United States (12)

Company Reports

SYNTHES Inc.

ref:plp2011

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.